Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Teratocarcinoma

fluorodeoxyglucose f18 has been researched along with Teratocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukushima, S; Hatazawa, J; Ito, E; Kashiyama, N; Kawamura, A; Kawamura, T; Masuda, S; Miyagawa, S; Morii, E; Sawa, Y; Toda, K; Watabe, T1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and Teratocarcinoma

ArticleYear
Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice.
    Scientific reports, 2016, Jan-14, Volume: 6

    Topics: Animals; Biopsy; Cell Line; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gene Order; Genetic Vectors; Graft Rejection; Immunocompromised Host; Immunosuppressive Agents; Induced Pluripotent Stem Cells; Male; Mice; Mice, Transgenic; Models, Animal; Myocytes, Cardiac; Positron-Emission Tomography; Stem Cell Transplantation; T-Lymphocyte Subsets; Tacrolimus; Teratocarcinoma; Transplantation, Homologous

2016